BLK unbelievably strong today, after a CR priced at 1.00 At hi of day (1.17) at time of Post. Another boat missed.....for now.....
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%